Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma

Oncogene

Volumn 18, Issue 20, 1999, Pages 3127-3134

  Pineau, Pascal ^a   Nagai, Hisaki ^a,c   Prigent, Sylvie ^a   Wei, Yu ^a   Gyapay, Gabor ^b,d   Weissenbach, Jean ^b,d   Tiollais, Pierre ^a   Buendia, Marie Annick ^a   Dejean, Anne ^a  

^a INSERM   (France)

^b GÉNÉTHON   (France)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d CENTRE NATIONAL DE SÉQUENÇAGE   (France)

Author keywords

Chromosome 8p; Hepatocellular carcinoma; Loss of heterozygosity; Microsatellite marker; Tumor suppressor gene

Indexed keywords

MICROSATELLITE DNA;

ADULT; ALLELE; ARTICLE; CHROMOSOME 8P; CONTROLLED STUDY; DELETION MUTANT; FEMALE; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0033587111     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202648     Document Type: Article

References (51)

1. Adelaide J, Chaffanet M, Imbert A, Allione F, Geneix J, Popovici C, van Alejwik D, Trapman J, Zeillinger R, Börresen-Dale A, Lidereau R, Birnbaum D and Pébusque M. (1998). Genes, Chrom. Cancer, 22, 186-199.
2. Anbazhagan R, Fujii H and Gabrielson E. (1998). Am. J. Pathol., 152, 815-819.
3. Becker SA. Zhou Y-Z and Slagle BL. (1996). Cancer Res., 56, 5092-5097.
4. Boige V, Laurent-Puig P, Fouchet P, Fléjou F, Monges G, Bedossa P, Bioulac-Sage P, Capron F, Schmitz A, Olschwang S and Thomas G. (1997). Cancer Res., 57, 1986-1990.
5. Brat DJ. Hahn SA, Griffin CA, Yeo CJ, Kern SC and Hruban RH. (1997). Am. J. Pathol., 150, 383-391.
6. Cher ML, McGrogan D, Bookstein R, Brown JA, Jenkins RB and Jensen RH. (1994). Genes, Chrom. Cancer, 11, 153-162.
7. CHLC-Généthon-CEPH. (1994). Science, 265, 2049-2054.
8. Chuaqui RF, Sanz-Ortega J, Vocke C, Linchan M, Sanz-Esponera J, Zhuang Z, Emmert-Buck MR and Merino MJ. (1995). Cancer Res., 55, 4995-4998.
9. Cliby W, Ritland S, Hartmann L, Dodson M, Halling KC, Keeney G, Podratz KC and Jenkins RB. (1993). Cancer Res., 53, 2393-2398.
10. Courjal F, Cuny M, Simony-Lafontaine J, Louason G, Speiser P, Zillinger R, Rodriguez C and Theillet C. (1997). Cancer Res., 57, 4360-4367.
11. Cunningham C, Dunlop MG, Wyllie AH and Bird CC. (1993). Oncogene, 7, 1391-1395.
12. DeSouza A, Hankins GR, Washington MK, Orton TC and Jirtle RL. (1995). Nature Genetics. 11, 447-449.
13. Devilee P and Cornelisse CJ. (1994). Bioch. Biophys. Acta., 1198, 113-130.
14. Dib C, Fauré S, Fizames C, Samson D, Drouot N, Vignal A, Millasscau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J and Weissenbach J. (1996). Nature, 380, (suppl, pp. A58-A63), 152-154
15. El-Naggar A, Coombes M, Batsakis J, Ki Hong W, Goepfert H and Kagan J. (1998). Oncogene, 16, 2983-2987.
16. El-Naggar A, Hurr K, Batsakis JG, Luna MA, Goepferl H and Huff V. (1995). Cancer Res., 55, 2656-2659.
17. Emi M, Fujiwara Y, Ohata H, Tsuda H, Hirohashi S, Koike M, Miyaki M, Monden M and Nakamura Y. (1993). Genes, Chrom. Cancer, 7, 152-157.
18. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA and Linchan WM. (1995). Cancer Res., 55, 2959-2962.
19. Farrington S, Cunningham C, Boyle S, Wyllie A and Dunlop M. (1996). Oncogene, 12, 1803-1808.
20. Fujiwara Y, Emi M, Ohata H, Kato Y, Nakajima T, Mori T and Nakamura Y. (1993a). Cancer Res., 53, 1172-1174.
21. Fujiwara Y, Monden M, Mori T, Nakamura Y and Emi M. (1993b). Cancer Res., 53, 857-860.
22. Fujiwara Y, Ohata H, Emi M, Okui K, Koyama K, Tsuchiya E, Nakajima T, Monden M, Mori T, Kurimasa A, Oshimura M and Nakamura Y, (1994). Genes, Chrom. Cancer, 10, 7-14.
23. Genome Data Base. (1997). http://gdbwww.org/ John Hopkins University School of Medicine: Baltimore, Maryland, USA.
24. Gronwald J, Storkel S, Holtgreve-Grez. H, Hadaczek P, Brinkschmidt C, Jauch A, Lubinski J and Cremer T. (1997). Cancer Res., 57, 481-487.
25. Gustafson CE, Wilson PJ, Lukeis R, Baker E, Woollatt E, Annab L, Hawke L, Barett JC and Chenevix-Trench G. (1996). Cancer Res., 56, 5238-5245.
26. Gyapay G, Schmitt K, Fizatnes C, Lones H, Vega-Czarny N, Spillett D, Muselel D, Prud'homme JF, Dib C, Auffray C, Murissette J, Weissenbach J and Goodfellow PN. (1996). Hum. Mol. Genet., 5, 339-346.
27. Hammoud ZT, Kaleem Z, Cooper JD, Sundaresan RS, Patterson GA and Goodfellow PJ. (1996). Cancer Res., 56, 4499-4502.
28. Hecker KH and Roux KH. (1996). Biotechniques, 20, 478-485.
29. James LA, Mitchell ELD, Menasee L and Varley JM. (1997). Oncogene, 14, 1059-1065.
30. Johansson B, Mertens F and Mitelman F. (1996). Genes, Chrom. Cancer, 16, 155-163.
31. Knowles MA, Shaw ME and Proctor AJ. (1993). Oncogene, 8, 1357-1364.
32. Litt M, Hauge X and Sharma V. (1993). Biotechniques, 15, 280-284.
33. Marchio A, Mehdeb M, Pineau P, Danglot G, Tiollais P, Bernheim A and Dejean A. (1997). Genes, Chrom. Cancer, 18, 59-65.
34. Nagai H, Pineau P, Tiollais P, Buendia MA and Dejean A. (1997). Oncogene, 14, 2927-2933.
35. Norder H, Courouce AM and Magnius LO. (1993). Arch. Virol., 8 (Suppl.), 189-199.
36. Pineau P, Marchio A, Mattei MG, Kim W-H, Youn J-K, Tiollais P and Dejean A. (1998). J. Gen. Virol., 79, 591-600.
37. Ried T, Knutzen R, Steinbeck R, Blegen H, Schröck E, Heselmeyer K, du Manoir S and Auer G. (1996). Genes, Chrom. Cancer, 15, 234-245.
38. Rosin MP, Cairns P, Epstein JI, Schoenberg MP and Sidransky D. (1995). Cancer Res., 55.
39. Roylance R, Spurr N and Sheer D. (1997). Sem. Cancer Biol., 8, 37-44.
40. Seitz S, Rohde K, Bender E, Nothnagel A, Kölbe K, Schlag PM and Scherneck S. (1997). Oncogene, 14, 741-743.
41. Sheffield VC, Weber JL, Buetow KH, Murray JC, Even DA, Wiles K, Gastier JM, Pulido JC, Yandava C, Sunden SL, Mattes G, Businga T, McClain A, Beck J, Scherpier T, Gilliam J, Zhong J and Duyk GM. (1995). Hum. Mol. Genet., 4, 1837-1844.
42. Simonic I and Gericke GS. (1996). Hum. Genet., 97, 524-531.
43. Sunwoo JB, Holt M, Radford DM, Deeker C and Scholnick S. (1996). Genes, Chrom. Cancer, 16, 164-169.
44. Tishkoff SA, Ruano G, Kidd JR and Kidd KK. (1996). Hum. Genet., 97, 759-764.
45. Tomfohrde J, Wood S, Schertzer M, Wagner MJ, Wells DE, Purrish J, Sadler LA, Blanton SH, Daiger SP, Wang Z, Wilkie PJ and Weber JL. (1992). Genomics, 14, 144-152.
46. Utah Marker Development Group. (1995). Am. J. Hum. Genet., 57, 619-628.
47. van Hul W, Wuyts W, Hendrick J, Speleman F, Wauters J, de Boulle K, van Roy N, Bossuyt P and Willems PJ. (1998). Genomics, 47, 230-237.
48. Vocke CD, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB, Strup SE, Duray PH, Liotta LA, Emmert-Buck MR and Linchan WM. (1996). Cancer Res., 56, 2411-2416.
49. Voorter C, Joos S, Bringuier P-P, Vallinga M, Poddighe P, Schalken J, du Manoir S, Ramackers F, Lichter P and Hopman A. (1995). Am. J. Pathol., 146, 1341-1354.
50. Wood S, Mitchell H and Schertzer M. (1991). Cytogenei. Cell Genet., 58, 1932-1935.
51. Wu CL, Roz L, Sloan P, Read AP, Holland S, Porter S, Scully C, Speight PM and Thakker N. (1997). Genes, Chrom. Cancer, 20, 347-353.